# Analysis of Relationships between Metabolic Changes and Selected Nutrient Intake in Women Environmentally Exposed to Arsenic

**Authors:** Monika Sijko-Szpańska, Lucyna Kozłowska

PMC · DOI: 10.3390/metabo14010075 · 2024-01-22

## TL;DR

This study explores how nutrient intake affects metabolic changes in women exposed to arsenic, suggesting that proper nutrition may help reduce arsenic-related health risks.

## Contribution

The study identifies specific nutrient-metabolite correlations in arsenic-exposed women, highlighting potential dietary interventions.

## Key findings

- Nutrient intake in low-arsenic-exposed women correlated with five metabolites, while in high-exposed women, it correlated with ten metabolites.
- Altering nutrient intake may reduce the negative impact of arsenic exposure on the human body.
- Specific metabolites like inosine and glutamine showed positive associations with nutrient intake in both groups.

## Abstract

Nutrients involved in the metabolism of inorganic arsenic (iAs) may play a crucial role in mitigating the adverse health effects associated with such exposure. Consequently, the objective of this study was to analyze the association between the intake levels of nutrients involved in iAs metabolism and alterations in the metabolic profile during arsenic exposure. The study cohort comprised environmentally exposed women: WL (lower total urinary arsenic (As), n = 73) and WH (higher As, n = 73). The analysis included urinary untargeted metabolomics (conducted via liquid chromatography–mass spectrometry) and the assessment of nutrient intake involved in iAs metabolism, specifically methionine, vitamins B2, B6, and B12, folate, and zinc (based on 3-day dietary records of food and beverages). In the WL group, the intake of all analyzed nutrients exhibited a negative correlation with 5 metabolites (argininosuccinic acid, 5-hydroxy-L-tryptophan, 11-trans-LTE4, mevalonic acid, aminoadipic acid), while in the WH group, it correlated with 10 metabolites (5-hydroxy-L-tryptophan, dihyroxy-1H-indole glucuronide I, 11-trans-LTE4, isovalerylglucuronide, 18-oxocortisol, 3-hydroxydecanedioic acid, S-3-oxodecanoyl cysteamine, L-arginine, p-cresol glucuronide, thromboxane B2). Furthermore, nutrient intake demonstrated a positive association with 3 metabolites in the WL group (inosine, deoxyuridine, glutamine) and the WH group (inosine, N-acetyl-L-aspartic acid, tetrahydrodeoxycorticosterone). Altering the intake of nutrients involved in iAs metabolism could be a pivotal factor in reducing the negative impact of arsenic exposure on the human body. This study underscores the significance of maintaining adequate nutrient intake, particularly in populations exposed to arsenic.

## Linked entities

- **Chemicals:** methionine (PubChem CID 876), vitamin B2 (PubChem CID 493570), vitamin B6 (PubChem CID 1054), vitamin B12 (PubChem CID 73415824), folate (PubChem CID 135405876), zinc (PubChem CID 23994)

## Full-text entities

- **Genes:** As3mt (arsenite methyltransferase) [NCBI Gene 57344] {aka 2310045H08Rik, Cyt19}, Crp (C-reactive protein, pentraxin-related) [NCBI Gene 12944], DDAH1 (dimethylarginine dimethylaminohydrolase 1) [NCBI Gene 23576] {aka DDAH, DDAH-1, DDAHI, HEL-S-16}, INS (insulin) [NCBI Gene 3630] {aka IDDM, IDDM1, IDDM2, ILPR, IRDN, MODY10}, HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) [NCBI Gene 3156] {aka LDLCQ3, LGMDR28, MYPLG}, KRT18 (keratin 18) [NCBI Gene 3875] {aka CK-18, CYK18, K18}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, Mph1 (macrophage antigen 1) [NCBI Gene 109782] {aka Mph-1}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}
- **Diseases:** type 2 diabetes (MESH:D003924), colorectal cancer (MESH:D015179), ovarian carcinomas (MESH:D010051), wound infections (MESH:D014946), CKD (MESH:D051436), inflammatory (MESH:D007249), schizophrenia (MESH:D012559), AISL (MESH:D020261), anxiety disorder (MESH:D001008), cancers of the lung, urinary bladder, and skin (MESH:D001749), systemic mastocytosis (MESH:D034721), injury to people or property (MESH:C000719191), carcinogenicity (MESH:D011230), neurodegenerative diseases (MESH:D019636), type 1 diabetes mellitus (MESH:D003922), cancers of the kidney, liver, and prostate (MESH:D011471), ACLF (MESH:D065290), polycystic ovarian syndrome (MESH:D011085), hyperthyroid (MESH:D006980), mitochondrial damage (MESH:D028361), hepatorenal syndrome (MESH:D006530), cognitive impairment (MESH:D003072), NSCL (MESH:D002289), cardiovascular, infectious, (MESH:D053821), Cancer (MESH:D009369), diabetes (MESH:D003920), Alzheimer's disease (MESH:D000544), skin lesions (MESH:D012871), toxicity (MESH:D064420), isovaleric acidemia (MESH:C538167), breast cancer (MESH:D001943), pulmonary hypertension (MESH:D006976), mental illness (MESH:D001523)
- **Chemicals:** 3-hydroxydecanedioic acid (MESH:C024036), acetonitrile (MESH:C032159), thyroxine (MESH:D013974), lysine (MESH:D008239), chromium (MESH:D002857), LTE4 (MESH:D017999), vitamin B6 (MESH:D025101), folate (MESH:D005492), arsenate (MESH:C025657), N-acetyl-L-aspartic acid (MESH:C000179), arsenobetaine (MESH:C038992), Inosine (MESH:D007288), Lipid (MESH:D008055), TXB2 (MESH:D013929), 18-hydroxycortisol (MESH:C033689), 18-oxocortisol (MESH:C038135), polyketides (MESH:D061065), Amino Acid (MESH:D000596), choline (MESH:D002794), Arsenic (MESH:D001151), hexavalent chromium (MESH:C074702), cholesterol (MESH:D002784), nitric oxide (MESH:D009569), vitamin B2 (MESH:D012256), GABA (MESH:D005680), B12 (MESH:C034730), 3-hydroxyisovaleric acid (MESH:C004961), water (MESH:D014867), cadmium (MESH:D002104), ADMA (MESH:C018524), pyrimidine nucleotide (MESH:D011742), methionine (MESH:D008715), nucleotide (MESH:D009711), triiodothyronine (MESH:D014284), lead (MESH:D007854), Cortisol (MESH:D006854), 5-hydroxy-L-tryptophan (MESH:D006916), carbohydrate (MESH:D002241), ergotamine (MESH:D004878), dimethylarsinic acid (MESH:D002101), THDOC (MESH:C009413), arsenic trioxide (MESH:D000077237), ammonium formate (MESH:C030544), 11-trans-LTE4 (-), arsenite (MESH:C015001), S-adenosyl-methionine (MESH:D012436), L-arginine (MESH:D001120), zinc (MESH:D015032), Glutamine (MESH:D005973), terpenoids (MESH:D013729), purine nucleoside (MESH:D011684), ubiquinone (MESH:D014451), copper (MESH:D003300), betaine (MESH:D001622), ozone (MESH:D010126), Mevalonic acid (MESH:D008798), monomethylarsonic acid (MESH:C020300), deoxyuridine (MESH:D003857), serotonin (MESH:D012701), L-tryptophan (MESH:D014364)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]
- **Cell lines:** MIN6-K8 — Mus musculus (Mouse), Mouse insulinoma, Transformed cell line (CVCL_A8QG), S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), BEAS-2B — Homo sapiens (Human), Transformed cell line (CVCL_0168), THP-1 — Homo sapiens (Human), Childhood acute monocytic leukemia, Cancer cell line (CVCL_0006)

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC10820439/full.md

---
Source: https://tomesphere.com/paper/PMC10820439